Joshua Schiffer, MD
Enriched profileProfessor, Infectious Disease Sciences Program, Vaccine and Infectious Disease Division, Fred Hutch · Fred Hutchinson Cancer Research Center
Joshua Schiffer is Professor, Infectious Disease Sciences Program, Vaccine and Infectious Disease Division, Fred Hutch at Fred Hutchinson Cancer Research Center. OpenAlex indexes 255 publications with 7,177 citations (h-index 44); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 23 Oct 2026
Joshua T. Schiffer, M.D., is Professor, Infectious Disease Sciences Program, Vaccine and Infectious Disease Division, Fred Hutch at Fred Hutchinson Cancer Research Center. The public record shows 255 publications with 7,177 citations (h-index 44), centered on SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, Herpesvirus Infections and Treatments. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 2 companies, 9 NIH-funded awards (2010–2026).
- Most recent indexed publication: 2026 · bioRxiv
- Top research focus: SARS-CoV-2 and COVID-19 Research
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 39 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 106.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- MMF for HIV Reservoir Reduction
Sponsor: Fred Hutchinson Cancer Center
Industry payments
Updated 23 Oct 2026
2 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20242 payments
- GlaxoSmithKline, LLC.Program year20231 payment
- Seagen Inc.Program year20211 payment
NIH funding
Updated 23 Oct 2026
9 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:
- Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
Fred Hutchinson Cancer Center
FY2026$828,228R01AI179457 - Development of an Oral Pan-Coronavirus Drug Cocktail
University of Washington
FY2026$666,354R01AI177512 - Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
Fred Hutchinson Cancer Center
FY2025$846,498R01AI179457
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Plasma concentrations of nirmatrelvir and molnupiravir required for inhibition of SARS-CoV-2 replication differ between rhesus macaques and humans.
Antimicrobial agents and chemotherapy
Article2026 - Is it "Time to Eliminate" Time to Elimination of Symptoms as a Primary Trial End Point for Drugs Targeting Respiratory Viruses?
The Journal of infectious diseases
Article2026
Most-cited works
by citation count (OpenAlex)- 01Early Remdesivir to Prevent Progression to Severe Covid-19 in OutpatientsArticle1,231 citations2021
- 02
- 03Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading eventsArticle200 citations2021
- 04
- 05
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 23 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/joshua-schiffer-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
- MD
Johns Hopkins University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - MS
Epidemiology, University of Washington
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mednews.uw.edu ↗
Secondary affiliations
appointments beyond the home institution- Professor
Clinical Research Division, Fred Hutch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Professor
Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Member
Pathogen-Associated Malignancies Integrated Research Center, Fred Hutch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Member
Translational Data Science Integrated Research Center, Fred Hutch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Sorror, MD
Fred Hutchinson Cancer Research Center
Mazyar Shadman, MD, MPH
Fred Hutchinson Cancer Research Center
Bart Scott, MD
Fred Hutchinson Cancer Research Center
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Richard Mayeux, MD
Columbia University College of Physicians and Surgeons